Search

Search Constraints

You searched for: Author/Creator Usansky, H.

Search Results

1. ASN002 demonstrates efficacy and improves inflammation in AD. (1st October 2019)

2. ASN002 证明有疗效并可改善AD 炎症. (1st October 2019)

3. The oral Janus kinase/spleen tyrosine kinase inhibitor ASN002 demonstrates efficacy and improves associated systemic inflammation in patients with moderate‐to‐severe atopic dermatitis: results from a randomized double‐blind placebo‐controlled study. (6th May 2019)

4. The oral Janus kinase/spleen tyrosine kinase inhibitor ASN002 demonstrates efficacy and improves associated systemic inflammation in patients with moderate‐to‐severe atopic dermatitis: results from a randomized double‐blind placebo‐controlled study. (1st October 2019)